Quantcast

Latest Diabetes mellitus type 1 Stories

2014-07-31 08:33:54

ALBANY, New York, July 31, 2014 /PRNewswire/ -- MarketResearchreports.biz presents this most up-to-date research on Global and China Insulin Market [http://www.marketresearchreports.biz/analysis/137594 ] (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019: Market Size, Trends, and Forecasts Research Report. Diabetes, growing at...

2014-07-30 16:28:55

-- JDRF Calls for CGM Medicare Coverage to Help Improve Health Outcomes Among Seniors with T1D and Advance an Artificial Pancreas -- WASHINGTON, July 30, 2014 /PRNewswire-USNewswire/ -- Today U.S. Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH), Co-chairs of the Senate Diabetes Caucus, introduced legislation to ensure that seniors with type 1 diabetes (T1D) who are Medicare eligible have access to continuous glucose monitors (CGM) as prescribed by their physicians. The...

2014-07-25 23:04:27

New report from the Juvenile Diabetes Cure Alliance analyzes the JDRF’s revenue and spending during fiscal year 2013 to find research spending down by $50 million since 2008 peak, while all other expense categories increased. New York, New York (PRWEB) July 25, 2014 A report released by the Juvenile Diabetes Cure Alliance reviews JDRF’s revenue and spending during fiscal year 2013 (July 1, 2012- June 30, 2013). Outside of the US government’s National Institutes of Health (NIH), the...

2014-07-21 23:03:13

Clinicians Discuss Future of Global Health Care; Diet as a First-Line Diabetes Treatment Washington, DC (PRWEB) July 21, 2014 New dietary guidelines for diabetes management, released at the International Conference on Diabetes (ICD), hosted by the George Washington University School of Medicine and the nonprofit Physicians Committee, favor low-fat, low-glycemic, plant-based foods, curbing sodium intake to 1,500 milligrams each day, and taking a vitamin B12 supplement. A panel of 35...

2014-07-21 12:24:39

Passionate volunteer will now lead organization toward life-changing treatments on path to ultimate cure for type one diabetes (T1D) NEW YORK, July 21, 2014 /PRNewswire/ -- JDRF's International Board of Directors (IBOD) announced today the appointment of Derek Rapp, currently Vice Chair of the JDRF International Board of Directors, as its new President and CEO. http://photos.prnewswire.com/prnvar/20140721/128866 Rapp replaces Jeffrey Brewer who recently left his role as JDRF...

2014-07-18 16:23:18

DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the "Global Type 1 Diabetes Market 2014-2018" [http://www.researchandmarkets.com/research/3txjqf/global_type_1 ] report to their offering. Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This,...

2014-07-17 23:05:17

Over the last two years, a dream team of diverse and talented scientists has been assembled at the University of Iowa’s Fraternal Order of Eagles Diabetes Research Center (FOEDRC) in collaboration to find new keys to preventing and curing this devastating disease. The community service organization Fraternal Order of Eagles (FOE) presented a $6 million donation to the University of Iowa at its national convention on Sunday, July 13, fulfilling a $25 million commitment made in 2008. Los...

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine company, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of the VC-01(TM) product candidate, a stem...

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-07-16 20:22:30

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Insulin Market Outlook 2018 https://www.reportbuyer.com/product/2080565/Global-Insulin-Market-Outlook-2018.html About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related